nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafcillin—CYP1A2—Carmustine—lymphatic system cancer	0.263	0.398	CbGbCtD
Nafcillin—SLC22A6—Methotrexate—lymphatic system cancer	0.101	0.153	CbGbCtD
Nafcillin—CYP3A4—Cytarabine—lymphatic system cancer	0.0942	0.142	CbGbCtD
Nafcillin—CYP3A4—Teniposide—lymphatic system cancer	0.0928	0.14	CbGbCtD
Nafcillin—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0649	0.0981	CbGbCtD
Nafcillin—CYP3A4—Vincristine—lymphatic system cancer	0.0446	0.0675	CbGbCtD
Nafcillin—Skin necrosis—Carmustine—lymphatic system cancer	0.00804	0.0237	CcSEcCtD
Nafcillin—Bone marrow depression—Teniposide—lymphatic system cancer	0.00739	0.0218	CcSEcCtD
Nafcillin—Bone marrow depression—Fludarabine—lymphatic system cancer	0.0065	0.0192	CcSEcCtD
Nafcillin—Local reaction—Bleomycin—lymphatic system cancer	0.00581	0.0171	CcSEcCtD
Nafcillin—Extravasation—Teniposide—lymphatic system cancer	0.00572	0.0169	CcSEcCtD
Nafcillin—Thrombophlebitis—Mechlorethamine—lymphatic system cancer	0.00568	0.0167	CcSEcCtD
Nafcillin—Proteinuria—Fludarabine—lymphatic system cancer	0.00499	0.0147	CcSEcCtD
Nafcillin—Protein urine present—Fludarabine—lymphatic system cancer	0.00492	0.0145	CcSEcCtD
Nafcillin—Local reaction—Mitoxantrone—lymphatic system cancer	0.00471	0.0139	CcSEcCtD
Nafcillin—Phlebitis—Teniposide—lymphatic system cancer	0.00421	0.0124	CcSEcCtD
Nafcillin—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.00403	0.0119	CcSEcCtD
Nafcillin—Bone marrow depression—Vincristine—lymphatic system cancer	0.00397	0.0117	CcSEcCtD
Nafcillin—Reaction gastrointestinal—Methotrexate—lymphatic system cancer	0.0039	0.0115	CcSEcCtD
Nafcillin—Bone marrow depression—Mitoxantrone—lymphatic system cancer	0.00387	0.0114	CcSEcCtD
Nafcillin—Skin necrosis—Methotrexate—lymphatic system cancer	0.00372	0.011	CcSEcCtD
Nafcillin—Phlebitis—Fludarabine—lymphatic system cancer	0.0037	0.0109	CcSEcCtD
Nafcillin—Extravasation—Bleomycin—lymphatic system cancer	0.00369	0.0109	CcSEcCtD
Nafcillin—Hepatotoxicity—Carmustine—lymphatic system cancer	0.00364	0.0107	CcSEcCtD
Nafcillin—Necrosis—Carmustine—lymphatic system cancer	0.00358	0.0106	CcSEcCtD
Nafcillin—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.00353	0.0104	CcSEcCtD
Nafcillin—Liver function test abnormal—Teniposide—lymphatic system cancer	0.00335	0.00987	CcSEcCtD
Nafcillin—Necrosis—Mitoxantrone—lymphatic system cancer	0.00333	0.00981	CcSEcCtD
Nafcillin—Extravasation—Carmustine—lymphatic system cancer	0.00322	0.00949	CcSEcCtD
Nafcillin—Bronchospasm—Teniposide—lymphatic system cancer	0.00308	0.00909	CcSEcCtD
Nafcillin—Extravasation—Vincristine—lymphatic system cancer	0.00307	0.00906	CcSEcCtD
Nafcillin—Skin exfoliation—Bleomycin—lymphatic system cancer	0.00307	0.00906	CcSEcCtD
Nafcillin—Extravasation—Mitoxantrone—lymphatic system cancer	0.00299	0.00883	CcSEcCtD
Nafcillin—Pancytopenia—Teniposide—lymphatic system cancer	0.00297	0.00877	CcSEcCtD
Nafcillin—Proteinuria—Mitoxantrone—lymphatic system cancer	0.00297	0.00876	CcSEcCtD
Nafcillin—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.00294	0.00867	CcSEcCtD
Nafcillin—Protein urine present—Mitoxantrone—lymphatic system cancer	0.00293	0.00864	CcSEcCtD
Nafcillin—Neutropenia—Teniposide—lymphatic system cancer	0.00293	0.00864	CcSEcCtD
Nafcillin—Nephropathy—Methotrexate—lymphatic system cancer	0.00273	0.00806	CcSEcCtD
Nafcillin—Stomatitis—Teniposide—lymphatic system cancer	0.00272	0.00803	CcSEcCtD
Nafcillin—Phlebitis—Bleomycin—lymphatic system cancer	0.00271	0.008	CcSEcCtD
Nafcillin—Skin exfoliation—Carmustine—lymphatic system cancer	0.00268	0.00791	CcSEcCtD
Nafcillin—Pancytopenia—Fludarabine—lymphatic system cancer	0.00261	0.00771	CcSEcCtD
Nafcillin—Neutropenia—Fludarabine—lymphatic system cancer	0.00257	0.00759	CcSEcCtD
Nafcillin—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00242	0.00713	CcSEcCtD
Nafcillin—Renal failure—Fludarabine—lymphatic system cancer	0.00241	0.00712	CcSEcCtD
Nafcillin—Stomatitis—Fludarabine—lymphatic system cancer	0.00239	0.00706	CcSEcCtD
Nafcillin—Phlebitis—Carmustine—lymphatic system cancer	0.00237	0.00698	CcSEcCtD
Nafcillin—Thrombophlebitis—Carmustine—lymphatic system cancer	0.00235	0.00695	CcSEcCtD
Nafcillin—Haematuria—Fludarabine—lymphatic system cancer	0.00234	0.0069	CcSEcCtD
Nafcillin—Swelling—Carmustine—lymphatic system cancer	0.00231	0.00682	CcSEcCtD
Nafcillin—Phlebitis—Mitoxantrone—lymphatic system cancer	0.0022	0.00649	CcSEcCtD
Nafcillin—Swelling—Mitoxantrone—lymphatic system cancer	0.00215	0.00634	CcSEcCtD
Nafcillin—Bronchospasm—Bleomycin—lymphatic system cancer	0.00198	0.00586	CcSEcCtD
Nafcillin—Bone marrow depression—Methotrexate—lymphatic system cancer	0.00193	0.00568	CcSEcCtD
Nafcillin—Pancytopenia—Bleomycin—lymphatic system cancer	0.00192	0.00565	CcSEcCtD
Nafcillin—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00188	0.00555	CcSEcCtD
Nafcillin—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00178	0.00525	CcSEcCtD
Nafcillin—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00178	0.00525	CcSEcCtD
Nafcillin—Stomatitis—Bleomycin—lymphatic system cancer	0.00175	0.00517	CcSEcCtD
Nafcillin—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.00175	0.00517	CcSEcCtD
Nafcillin—Malaise—Fludarabine—lymphatic system cancer	0.00173	0.0051	CcSEcCtD
Nafcillin—Haematuria—Bleomycin—lymphatic system cancer	0.00172	0.00506	CcSEcCtD
Nafcillin—Pruritus—Mechlorethamine—lymphatic system cancer	0.00171	0.00504	CcSEcCtD
Nafcillin—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00171	0.00503	CcSEcCtD
Nafcillin—Hepatotoxicity—Methotrexate—lymphatic system cancer	0.00168	0.00497	CcSEcCtD
Nafcillin—Pancytopenia—Carmustine—lymphatic system cancer	0.00167	0.00494	CcSEcCtD
Nafcillin—Hypotension—Teniposide—lymphatic system cancer	0.00166	0.00491	CcSEcCtD
Nafcillin—Necrosis—Methotrexate—lymphatic system cancer	0.00166	0.00489	CcSEcCtD
Nafcillin—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00165	0.00488	CcSEcCtD
Nafcillin—Neutropenia—Carmustine—lymphatic system cancer	0.00165	0.00486	CcSEcCtD
Nafcillin—Arthralgia—Fludarabine—lymphatic system cancer	0.00163	0.00482	CcSEcCtD
Nafcillin—Myalgia—Fludarabine—lymphatic system cancer	0.00163	0.00482	CcSEcCtD
Nafcillin—Discomfort—Fludarabine—lymphatic system cancer	0.00161	0.00476	CcSEcCtD
Nafcillin—Pancytopenia—Vincristine—lymphatic system cancer	0.0016	0.00471	CcSEcCtD
Nafcillin—Neutropenia—Vincristine—lymphatic system cancer	0.00157	0.00464	CcSEcCtD
Nafcillin—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00157	0.00462	CcSEcCtD
Nafcillin—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00156	0.00459	CcSEcCtD
Nafcillin—Renal failure—Carmustine—lymphatic system cancer	0.00154	0.00455	CcSEcCtD
Nafcillin—Vomiting—Mechlorethamine—lymphatic system cancer	0.00154	0.00453	CcSEcCtD
Nafcillin—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00153	0.00452	CcSEcCtD
Nafcillin—Stomatitis—Carmustine—lymphatic system cancer	0.00153	0.00452	CcSEcCtD
Nafcillin—Rash—Mechlorethamine—lymphatic system cancer	0.00152	0.00449	CcSEcCtD
Nafcillin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00152	0.00449	CcSEcCtD
Nafcillin—Extravasation—Methotrexate—lymphatic system cancer	0.00149	0.0044	CcSEcCtD
Nafcillin—Proteinuria—Methotrexate—lymphatic system cancer	0.00148	0.00437	CcSEcCtD
Nafcillin—Feeling abnormal—Teniposide—lymphatic system cancer	0.00147	0.00433	CcSEcCtD
Nafcillin—Stomatitis—Vincristine—lymphatic system cancer	0.00146	0.00431	CcSEcCtD
Nafcillin—Protein urine present—Methotrexate—lymphatic system cancer	0.00146	0.00431	CcSEcCtD
Nafcillin—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00146	0.0043	CcSEcCtD
Nafcillin—Renal failure—Mitoxantrone—lymphatic system cancer	0.00144	0.00423	CcSEcCtD
Nafcillin—Nausea—Mechlorethamine—lymphatic system cancer	0.00143	0.00423	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00143	0.00421	CcSEcCtD
Nafcillin—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00142	0.0042	CcSEcCtD
Nafcillin—Urticaria—Teniposide—lymphatic system cancer	0.00141	0.00417	CcSEcCtD
Nafcillin—Abdominal pain—Teniposide—lymphatic system cancer	0.00141	0.00415	CcSEcCtD
Nafcillin—Body temperature increased—Teniposide—lymphatic system cancer	0.00141	0.00415	CcSEcCtD
Nafcillin—Haematuria—Mitoxantrone—lymphatic system cancer	0.00139	0.00411	CcSEcCtD
Nafcillin—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00136	0.00402	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00135	0.00399	CcSEcCtD
Nafcillin—Inflammation—Methotrexate—lymphatic system cancer	0.00134	0.00396	CcSEcCtD
Nafcillin—Pain—Fludarabine—lymphatic system cancer	0.00134	0.00395	CcSEcCtD
Nafcillin—Hypersensitivity—Teniposide—lymphatic system cancer	0.00131	0.00387	CcSEcCtD
Nafcillin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.0013	0.00385	CcSEcCtD
Nafcillin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00129	0.0038	CcSEcCtD
Nafcillin—Malaise—Bleomycin—lymphatic system cancer	0.00127	0.00374	CcSEcCtD
Nafcillin—Pruritus—Teniposide—lymphatic system cancer	0.00126	0.00372	CcSEcCtD
Nafcillin—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00124	0.00366	CcSEcCtD
Nafcillin—Body temperature increased—Fludarabine—lymphatic system cancer	0.00124	0.00365	CcSEcCtD
Nafcillin—Diarrhoea—Teniposide—lymphatic system cancer	0.00122	0.00359	CcSEcCtD
Nafcillin—Myalgia—Bleomycin—lymphatic system cancer	0.0012	0.00353	CcSEcCtD
Nafcillin—Discomfort—Bleomycin—lymphatic system cancer	0.00118	0.00349	CcSEcCtD
Nafcillin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00115	0.0034	CcSEcCtD
Nafcillin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00115	0.00339	CcSEcCtD
Nafcillin—Vomiting—Teniposide—lymphatic system cancer	0.00113	0.00334	CcSEcCtD
Nafcillin—Rash—Teniposide—lymphatic system cancer	0.00112	0.00331	CcSEcCtD
Nafcillin—Dermatitis—Teniposide—lymphatic system cancer	0.00112	0.00331	CcSEcCtD
Nafcillin—Pruritus—Fludarabine—lymphatic system cancer	0.00111	0.00327	CcSEcCtD
Nafcillin—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00109	0.00322	CcSEcCtD
Nafcillin—Hypotension—Bleomycin—lymphatic system cancer	0.00107	0.00316	CcSEcCtD
Nafcillin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00107	0.00316	CcSEcCtD
Nafcillin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00106	0.00312	CcSEcCtD
Nafcillin—Nausea—Teniposide—lymphatic system cancer	0.00106	0.00312	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00105	0.00308	CcSEcCtD
Nafcillin—Myalgia—Carmustine—lymphatic system cancer	0.00104	0.00308	CcSEcCtD
Nafcillin—Malaise—Mitoxantrone—lymphatic system cancer	0.00103	0.00304	CcSEcCtD
Nafcillin—Myalgia—Vincristine—lymphatic system cancer	0.000997	0.00294	CcSEcCtD
Nafcillin—Vomiting—Fludarabine—lymphatic system cancer	0.000995	0.00294	CcSEcCtD
Nafcillin—Rash—Fludarabine—lymphatic system cancer	0.000987	0.00291	CcSEcCtD
Nafcillin—Dermatitis—Fludarabine—lymphatic system cancer	0.000986	0.00291	CcSEcCtD
Nafcillin—Pain—Bleomycin—lymphatic system cancer	0.000981	0.0029	CcSEcCtD
Nafcillin—Myalgia—Mitoxantrone—lymphatic system cancer	0.000971	0.00287	CcSEcCtD
Nafcillin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000971	0.00287	CcSEcCtD
Nafcillin—Discomfort—Mitoxantrone—lymphatic system cancer	0.00096	0.00283	CcSEcCtD
Nafcillin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000956	0.00282	CcSEcCtD
Nafcillin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000946	0.00279	CcSEcCtD
Nafcillin—Hypotension—Carmustine—lymphatic system cancer	0.000936	0.00276	CcSEcCtD
Nafcillin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000931	0.00275	CcSEcCtD
Nafcillin—Nausea—Fludarabine—lymphatic system cancer	0.00093	0.00274	CcSEcCtD
Nafcillin—Shock—Mitoxantrone—lymphatic system cancer	0.000916	0.0027	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000913	0.00269	CcSEcCtD
Nafcillin—Urticaria—Bleomycin—lymphatic system cancer	0.000912	0.00269	CcSEcCtD
Nafcillin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000907	0.00268	CcSEcCtD
Nafcillin—Hypotension—Vincristine—lymphatic system cancer	0.000894	0.00264	CcSEcCtD
Nafcillin—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000872	0.00257	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000871	0.00257	CcSEcCtD
Nafcillin—Hypotension—Mitoxantrone—lymphatic system cancer	0.00087	0.00257	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000865	0.00255	CcSEcCtD
Nafcillin—Pain—Carmustine—lymphatic system cancer	0.000857	0.00253	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000848	0.0025	CcSEcCtD
Nafcillin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000845	0.00249	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000826	0.00244	CcSEcCtD
Nafcillin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000825	0.00244	CcSEcCtD
Nafcillin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000819	0.00242	CcSEcCtD
Nafcillin—Pain—Vincristine—lymphatic system cancer	0.000818	0.00241	CcSEcCtD
Nafcillin—Pruritus—Bleomycin—lymphatic system cancer	0.000812	0.0024	CcSEcCtD
Nafcillin—Eosinophilia—Methotrexate—lymphatic system cancer	0.000808	0.00238	CcSEcCtD
Nafcillin—Pain—Mitoxantrone—lymphatic system cancer	0.000796	0.00235	CcSEcCtD
Nafcillin—Body temperature increased—Carmustine—lymphatic system cancer	0.000792	0.00234	CcSEcCtD
Nafcillin—Abdominal pain—Carmustine—lymphatic system cancer	0.000792	0.00234	CcSEcCtD
Nafcillin—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000782	0.00231	CcSEcCtD
Nafcillin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000782	0.00231	CcSEcCtD
Nafcillin—Pancytopenia—Methotrexate—lymphatic system cancer	0.000775	0.00229	CcSEcCtD
Nafcillin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000767	0.00226	CcSEcCtD
Nafcillin—Neutropenia—Methotrexate—lymphatic system cancer	0.000763	0.00225	CcSEcCtD
Nafcillin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000762	0.00225	CcSEcCtD
Nafcillin—Abdominal pain—Vincristine—lymphatic system cancer	0.000756	0.00223	CcSEcCtD
Nafcillin—Body temperature increased—Vincristine—lymphatic system cancer	0.000756	0.00223	CcSEcCtD
Nafcillin—Urticaria—Mitoxantrone—lymphatic system cancer	0.00074	0.00218	CcSEcCtD
Nafcillin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000738	0.00218	CcSEcCtD
Nafcillin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000736	0.00217	CcSEcCtD
Nafcillin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000736	0.00217	CcSEcCtD
Nafcillin—Vomiting—Bleomycin—lymphatic system cancer	0.00073	0.00215	CcSEcCtD
Nafcillin—Rash—Bleomycin—lymphatic system cancer	0.000724	0.00213	CcSEcCtD
Nafcillin—Dermatitis—Bleomycin—lymphatic system cancer	0.000723	0.00213	CcSEcCtD
Nafcillin—Renal failure—Methotrexate—lymphatic system cancer	0.000715	0.00211	CcSEcCtD
Nafcillin—Stomatitis—Methotrexate—lymphatic system cancer	0.000709	0.00209	CcSEcCtD
Nafcillin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000705	0.00208	CcSEcCtD
Nafcillin—Haematuria—Methotrexate—lymphatic system cancer	0.000694	0.00205	CcSEcCtD
Nafcillin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000686	0.00202	CcSEcCtD
Nafcillin—Diarrhoea—Carmustine—lymphatic system cancer	0.000685	0.00202	CcSEcCtD
Nafcillin—Nausea—Bleomycin—lymphatic system cancer	0.000682	0.00201	CcSEcCtD
Nafcillin—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000679	0.002	CcSEcCtD
Nafcillin—Diarrhoea—Vincristine—lymphatic system cancer	0.000654	0.00193	CcSEcCtD
Nafcillin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000637	0.00188	CcSEcCtD
Nafcillin—Vomiting—Carmustine—lymphatic system cancer	0.000637	0.00188	CcSEcCtD
Nafcillin—Rash—Carmustine—lymphatic system cancer	0.000632	0.00186	CcSEcCtD
Nafcillin—Dermatitis—Carmustine—lymphatic system cancer	0.000631	0.00186	CcSEcCtD
Nafcillin—Vomiting—Vincristine—lymphatic system cancer	0.000608	0.00179	CcSEcCtD
Nafcillin—Rash—Vincristine—lymphatic system cancer	0.000603	0.00178	CcSEcCtD
Nafcillin—Dermatitis—Vincristine—lymphatic system cancer	0.000602	0.00178	CcSEcCtD
Nafcillin—Nausea—Carmustine—lymphatic system cancer	0.000595	0.00176	CcSEcCtD
Nafcillin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000592	0.00175	CcSEcCtD
Nafcillin—Rash—Mitoxantrone—lymphatic system cancer	0.000587	0.00173	CcSEcCtD
Nafcillin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000587	0.00173	CcSEcCtD
Nafcillin—Nausea—Vincristine—lymphatic system cancer	0.000568	0.00168	CcSEcCtD
Nafcillin—Nausea—Mitoxantrone—lymphatic system cancer	0.000553	0.00163	CcSEcCtD
Nafcillin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000527	0.00156	CcSEcCtD
Nafcillin—Malaise—Methotrexate—lymphatic system cancer	0.000513	0.00151	CcSEcCtD
Nafcillin—Myalgia—Methotrexate—lymphatic system cancer	0.000484	0.00143	CcSEcCtD
Nafcillin—Arthralgia—Methotrexate—lymphatic system cancer	0.000484	0.00143	CcSEcCtD
Nafcillin—Discomfort—Methotrexate—lymphatic system cancer	0.000478	0.00141	CcSEcCtD
Nafcillin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000464	0.00137	CcSEcCtD
Nafcillin—Hypotension—Methotrexate—lymphatic system cancer	0.000434	0.00128	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000423	0.00125	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000401	0.00118	CcSEcCtD
Nafcillin—Pain—Methotrexate—lymphatic system cancer	0.000397	0.00117	CcSEcCtD
Nafcillin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000382	0.00113	CcSEcCtD
Nafcillin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000379	0.00112	CcSEcCtD
Nafcillin—Urticaria—Methotrexate—lymphatic system cancer	0.000369	0.00109	CcSEcCtD
Nafcillin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000367	0.00108	CcSEcCtD
Nafcillin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000367	0.00108	CcSEcCtD
Nafcillin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000342	0.00101	CcSEcCtD
Nafcillin—Pruritus—Methotrexate—lymphatic system cancer	0.000328	0.000968	CcSEcCtD
Nafcillin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000317	0.000937	CcSEcCtD
Nafcillin—Vomiting—Methotrexate—lymphatic system cancer	0.000295	0.00087	CcSEcCtD
Nafcillin—Rash—Methotrexate—lymphatic system cancer	0.000293	0.000863	CcSEcCtD
Nafcillin—Dermatitis—Methotrexate—lymphatic system cancer	0.000292	0.000862	CcSEcCtD
Nafcillin—Nausea—Methotrexate—lymphatic system cancer	0.000276	0.000813	CcSEcCtD
